| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Eur J Cardiothorac Surg 2003;23:818-823
© 2003 Elsevier Science NL
kea
a Department of Surgery, University of Szeged, Szeged, Hungary
b Department of Pathology, University of Szeged, Szeged, Hungary
c Department of Radiology, University of Szeged, Szeged, Hungary
d Department of Medical Informatics, University of Szeged, Szeged, Hungary
Received 22 September 2002; received in revised form 26 January 2003; accepted 3 February 2003.
* Corresponding author. Tel.: +36-30-99-55-815; fax: +36-62-545-701
e-mail: fj{at}surg.szote.u-szeged.hu
Objective: The prevalence of pulmonary adenocarcinoma has risen worldwide. Bronchioloalveolar carcinoma (BAC) was studied with regard to whether it exhibits a similar tendency, and its typical features were analysed. Methods: Between 1992 and 2001, 278 lung resections were carried out for adenocarcinoma. Of these, 67 (24.1%) proved to involve BAC. Whereas BAC accounted for 6.9% of the cases in 1992, in 2001 the proportion was 46.9%. There were 37 men (55.2%) and 30 women (44.7%); the average age was 60.5 years. 58.2% of them had no complaints. Of the 26 non-smokers, 69.2% were women; of the 41 smokers, 29.2% were women. In consequence of the tumour, 49 lobectomies, three bilobectomies, six pneumonectomies and nine wedge resections were performed. Results: The surgical mortality was 1.6%. The pathology revealed that 26 (38.8%) tumours were in stage I/A. In 15 cases (22.4%), tuberculosis (TB) could be revealed besides the BAC: by skin tests in four cases, by CT in three cases, by case history in four cases, and by pathology in four cases. For the overall group of 67 patients, the 5-year survival rate was 61.9%, and the mean survival time was 75.7 months. The 5-year survival rate among the women (74%) was significantly better than that among the men (37%) (P=0.030). There was no significant difference in survival with regard to the multiple BAC (85%). The 5-year survival rate was significantly worse in the mixed BAC group (20%) than in the non-mucinous (62.7%) and in mucinous (59%) group. The overall 5-year survival rate among the smokers and TB patients was 61 and 79%, respectively, which is higher than that among the non-smokers (47%) and non-TB patients (56%). The survival rate for the wedge resection cases was 37%, which was lower than that for the cases involving major resections (60%) (P=0.939). Conclusion: BAC has a favourable survival, particularly in women. In spite of this, resection smaller than lobectomy is recommended only as a compromise. A multiple appearance does not imply a worse survival. The best survival rate was found in the non-mucinous BAC among the histological groups. TB seems to be frequent among BAC patients.
Key Words: Bronchioloalveolar carcinoma • Survival • Scar-carcinoma • Smokers
This article has been cited by other articles:
|
|
 |
|
  M. P. Poullis and R. Warwick Re: Bronchiolo-alveolar lung cancer: occurrence, surgical treatment and survival Eur. J. Cardiothorac. Surg., November 1, 2009; 36(5): 941 - 941. [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Shaw, P. A. Bejarano, and R. J. Thurer Pseudocavitating Bronchioloalveolar Carcinoma Followed Over a Decade Ann. Thorac. Surg., April 1, 2008; 85(4): 1432 - 1434. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Raz, A. Y. Odisho, B. L. Franc, and D. M. Jablons Tumor fluoro-2-deoxy-D-glucose avidity on positron emission tomographic scan predicts mortality in patients with early-stage pure and mixed bronchioloalveolar carcinoma. J. Thorac. Cardiovasc. Surg., November 1, 2006; 132(5): 1189 - 1195. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Raz, B. He, R. Rosell, and D. M. Jablons Current concepts in bronchioloalveolar carcinoma biology. Clin. Cancer Res., June 15, 2006; 12(12): 3698 - 3704. [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Zell, S.-H. I. Ou, A. Ziogas, and H. Anton-Culver Epidemiology of Bronchioloalveolar Carcinoma: Improvement in Survival After Release of the 1999 WHO Classification of Lung Tumors J. Clin. Oncol., November 20, 2005; 23(33): 8396 - 8405. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. R. Hirsch, M. Varella-Garcia, J. McCoy, H. West, A. C. Xavier, P. Gumerlock, P. A. Bunn Jr, W. A. Franklin, J. Crowley, and D. R. Gandara Increased Epidermal Growth Factor Receptor Gene Copy Number Detected by Fluorescence In Situ Hybridization Associates With Increased Sensitivity to Gefitinib in Patients With Bronchioloalveolar Carcinoma Subtypes: A Southwest Oncology Group Study J. Clin. Oncol., October 1, 2005; 23(28): 6838 - 6845. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. D. Shaw and E. L. Hoover Postoperative Pleural Effusion in Bronchioloalveolar Cancer Ann. Thorac. Surg., September 1, 2005; 80(3): 1124 - 1126. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. D. Travis, K. Garg, W. A. Franklin, I. I. Wistuba, B. Sabloff, M. Noguchi, R. Kakinuma, M. Zakowski, M. Ginsberg, R. Padera, et al. Evolving Concepts in the Pathology and Computed Tomography Imaging of Lung Adenocarcinoma and Bronchioloalveolar Carcinoma J. Clin. Oncol., May 10, 2005; 23(14): 3279 - 3287. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. A. Miller, F. R. Hirsch, and D. H. Johnson Systemic Therapy of Advanced Bronchioloalveolar Cell Carcinoma: Challenges and Opportunities J. Clin. Oncol., May 10, 2005; 23(14): 3288 - 3293. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Sakurai, Y. Dobashi, E. Mizutani, H. Matsubara, S. Suzuki, K. Takano, S. Shindo, and M. Matsumoto Bronchioloalveolar Carcinoma of the Lung 3 Centimeters or Less in Diameter: A Prognostic Assessment Ann. Thorac. Surg., November 1, 2004; 78(5): 1728 - 1733. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
